0.00
—
Close of 30 Oct 2026, in USD
About Vasamed
Its shares trade under the ticker VSMD. It has been listed since 14 February 1996. In the fiscal year to 31 December 2008, it reported revenue of $3.1m and a net loss of $2.9m. At that date it held total assets of $1.6m and shareholders' equity of −$1.2m.
Väsamed, Inc. designs, licenses, manufactures and distributes a range of non-invasive hemodynamic technologies for vascular, wound care, cardiovascular and emergency medicine diagnostics. The company is headquartered in Eden Prairie, Minnesota. Its SensiLase peripheral arterial disease (PAD)-IQ Studycast System provides measurement of tissue perfusion of the extremities particularly in patients with combined peripheral arterial disease and diabetes. The SensiLase PAD-IQ Studycast supports non-invasive upper and lower extremity vascular assessments, including skin perfusion pressure microcirculation pulse volume recording and ankle brachial index (ABI) calculation for doppler-obtained pressures; data sorting and customization options to support database mining, and wound imaging and surface area calculation featuring SmartDraw. SensiLase PAD-IQ System featuring Studycast Data Management offers health professionals various support tools for both PAD and critical limb ischemia. Its AcQtrac System technology is designed to measure cardiac and hemodynamic parameters.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- N/A
- Industry
- N/A
- Listed since
- 14 Feb 1996
- Employees
- 31
- Website
- vasamed.com ↗
Leadership
Pay as last reported
- Ms. Paulita LaPlantePresident and Chief Executive Officer and Director, since 1994$180,000
- Ms. Roberta DircksChief Financial Officer, Vice President - Finance and Administration
- Mr. Kent WingerVice President - Operations$108,160
- Mr. Terry DuesterhoeftVice President of Sales and Marketing$180,923
- Mr. Richard EgenDirector
- DR. Andrew JayDirector
- Dr. Charles SneadDirector
- Dr. Craig WalkerDirector
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Vasamed Inc has a strong reputation in the medical technology industry, known for its innovative and cutting-edge products.
- The company has a highly skilled and experienced R&D team, enabling it to develop advanced and efficient solutions for patient monitoring and diagnostics.
- Vasamed Inc possesses a diverse portfolio of products, catering to various medical specialties and addressing a wide range of healthcare needs.
Weaknesses
- One of the weaknesses for Vasamed Inc is the high cost associated with its products, limiting their accessibility to certain healthcare facilities and geographical regions.
- The company relies heavily on its distribution network, which can be a vulnerability in terms of maintaining consistent market presence and addressing customer demands directly.
- Vasamed Inc may face challenges related to regulatory compliance and changing industry standards, requiring constant adaptability and updates to its products.
Opportunities
- The growing demand for remote patient monitoring presents an opportunity for Vasamed Inc to expand its market presence and offer solutions that facilitate telemedicine and home healthcare.
- International expansion into emerging markets, where there is a rising need for advanced medical technologies, can provide Vasamed Inc with new revenue streams and a broader customer base.
- Collaborations and partnerships with research institutions and healthcare organizations can enable Vasamed Inc to remain at the forefront of medical innovation and establish itself as a leader in the field.
Threats
- Intense competition within the medical technology industry poses a threat to Vasamed Inc's market position, requiring continuous product advancement and differentiation to stay ahead.
- Economic downturns or financial instability can impact healthcare spending, potentially leading to reduced demand for Vasamed Inc's products and services.
- Changes in healthcare policies and regulations, both nationally and internationally, can introduce uncertainties and compliance challenges for Vasamed Inc, affecting its operations and market access.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.